Microbial Consortium for Low-Temperature Casein-Free Dairy Fermentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing dairy derivatives with low casein content are costly due to the use of enzymatic processes, which also lead to nutritional degradation and require additional nutrient supplementation, and existing microorganisms are inefficient at lower temperatures.

Innovation Solution

A group of microorganisms composed of Lactobacillus sp. strain K03D08, Bacillus sp. strain K03B01, and Kazachstania sp. strain K03K02G is used to hydrolyze casein at lower temperatures (26° C.-37° C.), producing a casein-free dairy derivative enriched with short-chain fatty acids and hydroxylated short-chain fatty acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If proteolytic enzymes are used to hydrolyze casein, then casein content is reduced, but production costs increase due to expensive enzyme inputs

Engineering Contradiction:
Improvecasein contentVSAvoidproduction cost
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent replaces expensive proteolytic enzymes with a microbial consortium that can be cultured and used as a cost-effective alternative. The microorganisms (Lactobacillus sp., Bacillus sp., and Streptococcus sp.) serve as disposable biological agents that hydrolyze casein through their natural proteolytic activity, eliminating the need for costly commercial enzyme preparations while achieving the desired casein reduction in dairy derivatives

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The microbial consortium performs casein hydrolysis through its own metabolic processes and secreted enzymes. The microorganisms self-regulate the hydrolysis reaction, producing peptides and amino acids as they metabolize casein, thereby eliminating the need for external enzyme additions and reducing production costs associated with commercial enzyme preparations

Inventive Principle:
Principle #25Self-service

2Quantity of substance

If thermal treatments or acid/alkaline hydrolysis are used to reduce casein, then casein content is reduced, but nutritional value deteriorates due to amino acid degradation

Engineering Contradiction:
Improvecasein contentVSAvoidnutritional value
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent replaces harsh physical-chemical methods (thermal treatment, acid/alkaline hydrolysis) with a biological system. The microbial consortium uses enzymatic hydrolysis under mild conditions (physiological pH and temperature) to break down casein, preserving the nutritional integrity of amino acids while achieving effective casein reduction. This biological substitution eliminates the severe degradation associated with extreme thermal or chemical conditions

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the operational parameters from extreme conditions (high temperature, extreme pH) to mild physiological conditions (37°C, neutral pH) by using living microorganisms. This parameter change enables casein hydrolysis to proceed effectively while preserving the nutritional value of amino acids, as the microbial enzymes function optimally under gentle conditions that prevent amino acid degradation

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If traditional hydrolysis processes are carried out at 45-60°C, then casein hydrolysis is achieved, but energy costs increase to maintain temperature

Engineering Contradiction:
Improvecasein hydrolysis efficiencyVSAvoidenergy cost for temperature maintenance
Core Design Contradiction:
Quantity of substanceVSUse of energy by stationary object

Solution Approach 1:

The patent reduces the operational temperature from 45-60°C to 37°C by using a microbial consortium adapted to physiological temperatures. The microorganisms (Lactobacillus sp., Bacillus sp., and Streptococcus sp.) maintain high proteolytic activity at 37°C, eliminating the need for expensive temperature maintenance while achieving effective casein hydrolysis. This parameter change significantly reduces energy costs associated with heating and temperature control

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The microbial consortium generates its own optimal thermal environment through metabolic heat production during active growth and enzyme secretion. The microorganisms self-regulate the hydrolysis process at their optimal growth temperature (37°C), eliminating the need for external energy input to maintain temperature, thereby reducing operational energy costs while maintaining high hydrolysis efficiency

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process significantly reduces casein content to less than 0.5% w/v, achieves efficient hydrolysis at lower temperatures, and avoids the high costs associated with enzymatic methods, while maintaining nutritional value.

Implementation Method 1

the use of microorganisms has taken a relevant importance... capable of degrading the different substrates available in their environment so that they can be metabolized as monomeric units. Among the enzymes of interest are the proteases

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

producing short-chain fatty acids and hydroxylated short-chain fatty acids, are used in a process optimized at lower temperatures (26° C.-37° C.) to create a casein-free dairy derivative

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS12628840B2Group of microorganisms composed by <i>Lactobacillus </i>sp strain K03D08, <i>Bacillus </i>sp strain K03B01 and <i>Kazachstania </i>sp strain K03K02G and its compositions; a process for obtaining casein-free dairy derivative containing short-chain fatty acids and hydroxylated short-chain fatty acids generated by the metabolism of the group of microorganisms
Publication Date: 2026.05.19 UNIV DE VALPARAISO
  • US12628840B2 patent drawing
  • US12628840B2 patent drawing

AI summary

A group of microorganisms, composed of Lactobacillus sp. strain K03D08, Bacillus sp. strain K03B01 and Kazachstania sp. strain K03K02G, which allows the hydrolysis of casein in different dairy products and the production of short-chain fatty acids and hydroxylated short-chain fatty acids; a process for obtaining a casein-free dairy derivative and enriched in short-chain fatty acids and hydroxylated short-chain fatty acids using the aforementioned microorganisms; compositions containing the microorganisms; and the production method of each of the microorganisms.